Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Trabectedin 250microgram inf vials
0801050AVAAAAAA
|
Trabectedin | Trabectedin | Malignant Disease and Immunosuppression | No data available |
|
Trametinib 2mg tablets
0801050CHAAABAB
|
Trametinib | Trametinib | Malignant Disease and Immunosuppression | No data available |
|
Trametinib 500micrograms tablets
0801050CHAAAAAA
|
Trametinib | Trametinib | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 150mg powder for solution for infusion vials
0801050ADAAAAAA
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 420mg powder for solution for infusion vials
0801050ADAAAEAE
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 600mg/5ml solution for injection vials
0801050ADAAABAB
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 60mg powder for solution for infusion vials
0801050ADAAAFAF
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab emtansine 100mg inf vials
0801050ADAAACAC
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab emtansine 160mg inf vials
0801050ADAAADAD
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trazimera 150mg pdr for concentrate for inf vials
0801050ADBGAAAA
|
Trazimera | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trazimera 420mg pdr for concentrate for inf vials
0801050ADBGABAE
|
Trazimera | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trecondi 1g powder for solution for infusion
0801010Z0BBAAAD
|
Trecondi | Treosulfan | Malignant Disease and Immunosuppression | No data available |
|
Trecondi 5g powder for solution for infusion
0801010Z0BBABAB
|
Trecondi | Treosulfan | Malignant Disease and Immunosuppression | No data available |
|
Treosulfan 1g powder for solution for injection vials
0801010Z0AAADAD
|
Treosulfan | Treosulfan | Malignant Disease and Immunosuppression | No data available |
|
Treosulfan 250mg capsules
0801010Z0AAACAC
|
Treosulfan | Treosulfan | Malignant Disease and Immunosuppression | No data available |
|
Treosulfan 5g powder for solution for injection vials
0801010Z0AAABAB
|
Treosulfan | Treosulfan | Malignant Disease and Immunosuppression | No data available |
|
Trifluridine 15mg / Tipiracil 6.14mg tablets
0801030AFAAAAAA
|
Trifluridine/tipiracil | Trifluridine/tipiracil | Malignant Disease and Immunosuppression | No data available |
|
Trifluridine 20mg / Tipiracil 8.19mg tablets
0801030AFAAABAB
|
Trifluridine/tipiracil | Trifluridine/tipiracil | Malignant Disease and Immunosuppression | No data available |
|
Trisenox 10mg/10ml concentrate for inf ampoules
0801050AIBBAAAA
|
Trisenox | Arsenic | Malignant Disease and Immunosuppression | No data available |
|
Truxima 100mg/10ml concentrate for inf vials
0802030F0BCABAB
|
Truxima | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Truxima 500mg/50ml concentrate for inf vials
0802030F0BCAAAA
|
Truxima | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Tyruko 300mg/15ml concentrate for inf vials
0802040W0BCAAAA
|
Tyruko | Natalizumab | Malignant Disease and Immunosuppression | No data available |
|
Tysabri 300mg/15ml concentrate for inf vials
0802040W0BBAAAA
|
Tysabri | Natalizumab | Malignant Disease and Immunosuppression | No data available |
|
Tyverb 250mg tablets
0801050ATBBAAAA
|
Tyverb | Lapatinib | Malignant Disease and Immunosuppression | No data available |
|
Uftoral capsules
0801030S0BCAAAB
|
Uftoral | Tegafur | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.